ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in July 2026. Updated July 6.
A roundup of FDA’s actions in July 2026.
FDA Output, July 2026
×
